FIELD: medicine.
SUBSTANCE: offered pharmaceutical formulation with anticoagulative and antiaggregatory action contains sodium heparin as reactant and carbomers 940 or 980, trisamine, lavender oil, neroli oil and water as adjuvants taken in specific proportions. Pharmaceutical formulation has gel consistency. Method of production of offered formulation includes sodium heparin aqueous solution, nypagin solution, ethanol solution of lavender and neroli oil, and trisamine sequentially added to water-dispersed carbomers.
EFFECT: new formulation is characterised by high pharmaceutical activity; does not have by-effects; stable for keeping; has optimal viscosity and applicable organoleptic property.
4 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION WITH ANALGETIC AND ANTI-INFLAMMATORY EFFECT | 2003 |
|
RU2238722C1 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTI-INFLAMMATORY AND ANALGESIC EFFECT AND METHOD FOR ITS PREPARING | 2006 |
|
RU2309738C1 |
PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE CONTAINING A SALT OF DEXKETOPROFEN, AND A PROCESS FOR ITS PREPARATION | 2015 |
|
RU2667465C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING LOCOMOTOR DISORDERS | 2013 |
|
RU2550916C1 |
STABILISED PHARMACEUTICAL GEL WITH ANALGESIC AND ANTI-INFLAMMATORY ACTION | 2011 |
|
RU2450811C1 |
COMBINED CHONDROPROTECTIVE PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2381029C1 |
ARTHRONOSOS CURE | 2007 |
|
RU2353349C2 |
ANTIVIRAL PHARMACEUTICAL COMPOSITION | 2013 |
|
RU2538082C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VEIN DISEASES AND METHOD FOR ITS PREPARING | 2005 |
|
RU2299070C2 |
STABILISED PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES CAUSED BY VENOUS INSUFFICIENCY | 2011 |
|
RU2458694C1 |
Authors
Dates
2008-06-20—Published
2006-11-27—Filed